How does a nonprofit innovate and scale its mission? Joining me today is Alice Pomponio, Managing Director of BrightEdge, the venture arm of the American Cancer Society, to discuss the intersection of venture capital and nonprofit work. Is this approach a unique case, or part of a new wave of strategies catalyzing the defeat of cancer and other societal challenges?
Episode Highlights
- BrightEdge, the innovation and venture capital arm of the American Cancer Society (ACS), aims to bridge the gap between scientific discovery and practical application, creating a new funding source for the nonprofit.
- ACS has allocated over $5 billion to 25,000 researchers and 50 Nobel laureates, significantly influencing global cancer research.
- Capitalizing on the ACS’s extensive partnership network and volume of grants, BrightEdge enhances its deal flow and supports innovative cancer care solutions, ranging from therapeutics to care delivery.
- The newly announced Texas Accelerator by ACS highlights the strategic importance of the region in advancing national cancer research efforts, leveraging local capabilities, and enhancing ACS's impact through innovative cancer care approaches.
- What's Next?
- "Bright Edge is investing in innovation for impact. So we are really excited about reporting on our impact performance. We're excited about the accelerators taking flight and we're excited about building community"
What is Austin Next?
Austin's transformation into a global innovation powerhouse is at the heart of Austin Next. We explore insights into the region's evolution and the building of robust ecosystems. Additionally, we delve into the potential impact of emerging trends, technologies, and their convergence.
Austin, as our real-world case study, helps us aspire to better comprehend the true nature of innovation.